Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00485394Phase 2Unknown
A Phase 2 trial of OT-551 in geographic atrophy (GA), sponsored by Othera Pharmaceuticals, Inc.. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00485394.